Food allergies in children involve an abnormal immune response to specific foods, with common triggers including milk, eggs, peanuts, tree nuts, soy, wheat, fish, and shellfish. Symptoms can range from mild, such as hives and itching, to severe, including anaphylaxis, a life-threatening reaction. Diagnosing food allergies often involves a combination of medical history, skin tests, and blood tests. Prevalence is on the rise, and strict avoidance of allergenic foods is the primary management strategy. Children with food allergies may require an emergency action plan, including the use of epinephrine in case of severe reactions. Schools and caregivers play a crucial role in ensuring a safe environment for allergic children. Ongoing research explores preventive measures, such as early introduction of certain foods, to reduce the risk of developing allergies. Managing food allergies in children necessitates vigilant awareness, education, and proactive measures to ensure their safety and well-being.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States